Peptide Pharmaceuticals: Opportunities, Prospects, and Limitations


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

Currently, a number of peptide pharmaceuticals are widely used in medical practice, but the market size of such drugs remains relatively small. However, in the coming years, one can expect a significant increase in interest in peptide pharmaceuticals, which is primarily due to their low toxicity and wide range of possible molecular targets. The results obtained in recent years allow us to take a new approach to the development of such drugs, which will make it possible to expand the range of possible applications of peptide drugs and improve their efficiency and usability.

Авторлар туралы

P. Slominsky

Institute of Molecular Genetics

Email: shadrina@img.ras.ru
Ресей, Moscow, 123182

M. Shadrina

Institute of Molecular Genetics

Хат алмасуға жауапты Автор.
Email: shadrina@img.ras.ru
Ресей, Moscow, 123182

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Allerton Press, Inc., 2018